Thyroxine and progesterone levels in cows and heifers after administration of Oestrophan (Spofa) in the luteal phase of the cycle

Thyroxine and progesterone levels were studied in cows and heifers in the luteal stage of the cycle after the application of the synthetic analogue of prostaglandine of group F2 alpha: Oestrophan Spofa. The preparation was administered at a rate of 0.5 mg in 2 ml per animal. The thyroxine and progesterone levels were determined radioimmunologically. The administration of Oestrophan led to a reduction in the progesterone level from the initial value of 17.33 +/- 2.73 nmol/l of serum to 7.69 +/- 1.17 nmol/l of serum an hour after the application, followed by slow decrease below the value 1.59 +/- 0.22 nmol/l of serum at the 24th hour. The initial levels of thyroxine with the average values of 122.11 +/- 23.41 nmol/l of serum were comparatively high. An hour from application of the preparation, a significant decrease to the average levels of 88.14 +/- 16.26 nmol/l of serum (P less than 0.05) was recorded with a significant negative correlation. The correlation coefficient r = -83316, P less than 0.01. The thyroxine level decreases to the values of 24.20 +/- 9.26 nmol/l of serum and 24.12 +/- 6.68 nmol/l of serum, P less than 0.01, at the 52nd to 56th hour, i. e. at the time when the pre-ovulation peak of oestrogens can be expected. A statistically significant correlation--even despite the fact that a highly significant decline in thyroxine and progesterone had been observed--was recorded in none of the cases in the subsequent period of study, except the first hour. It can be assumed from the results that the thyroid hormones are among the links acting at more levels of the regulatory biological circuit responsible for the physiological course of ovulation and reproduction process.     

Evaluation of a regimen using a progesterone releasing intravaginal device (CIDR) and PMSG as a treatment for post partum anoestrus in dairy cattle

Anoestrous dairy cows in seasonally calving herds in the Macalister Irrigation District of Gippsland, Victoria were treated at the start of the mating period with a progesterone releasing intravaginal device (CIDR). The CIDR was inserted for 7 days and 400 IU of PMSG was injected intramuscularly at removal. There was no clinically useful difference among cows receiving the CIDR, a placebo and untreated cows in the interval from treatment to either first oestrus or conception, the conception rate to first service or percent pregnant by the end of mating. Analyses of data from 2-year-old cows, older cattle, cows calved at least 45 days or cows calved at least 55 days and cows treated 3 weeks after the start of mating did not show improved reproductive performance following treatment with the CIDR.     

Impact of norgestomet supplementation during early luteal phase on subsequent luteal profiles and conception rate in buffalo: a preliminary study

The current study was aimed to establish the impact of progesterone supplementation (norgestomet progestagen) between days 4 to 10 post-ovulation on subsequent luteal profile and conception rate in buffaloes. The 28 Murrah buffaloes of second to fourth parity, having normal reproductive organs, were estrus synchronized by double PGF_2α protocol at 11 days apart. The buffaloes were inseminated during mid- to late estrus and thereafter repeated at 24 h interval. The buffaloes were randomly assigned into two groups: (1) control (no treatment, n?=?14) and (2) treatment group (CRESTAR ear implant, n?=?14). The CRESTAR ear implant (3 mg, norgestomet progestagen) was inserted subcutaneous between days 4 to 10 post-ovulation. The ovaries were scanned at estrus and thereafter on days 4, 10, 16, 21, and 40 post-ovulation to examine the preovulatory follicle (POF) and corpus luteum (CL) diameter. Each ultasonography was followed by blood sample collection for analysis of plasma progesterone concentrations following ovulation. The conception rate was similar (p?>?0.05) between treated and control buffaloes. The pregnant buffalo of the control group had larger (p?<?0.05) POF diameter than nonpregnant counterparts. The CL diameter was similar (p?>?0.05) in both treated and untreated control as well as in their pregnant and nonpregnant buffaloes of the respective groups. The plasma progesterone concentrations were higher (p?<?0.05) in the treatment group on the day 10 post-ovulation as compared to the control buffaloes. It is concluded that norgestomet supplementation had no impact on conception rate and CL diameter but enhances the plasma progesterone concentrations following treatment in buffaloes.     

Concentration of progesterone and thyroxine in the luteal phase of the cycle in heifers after administration of estradiol benzoate

The effect of current 48-hour infusion of estradiol benzoate (EB) on the dynamics of the concentration of progesterone (P) and thyroxine (T4) was studied in four heifers in the luteal stage of their cycle. The parameters were evaluated in three intervals: infusion (A), post-infusion (B) and "uninfluenced" interval (C). In the course of infusion the concentrations of P in three animals had a markedly descending tendency. The P concentration increase in the 36th hour of infusion was maintained also during the post-infusion interval. The decrease in P in the third, "uninfluenced", interval was replaced by a new rise towards the end. One heifer showed an increase in P concentrations at the beginning of EB infusion. A decrease was recorded towards the end of the interval. The concentration decreased in the post-infusion period. A comparatively high concentration of P in the "uninfluenced" interval was again replaced by a drop towards the end in the 286th hour. The concentration of T4 in three heifers had a descending tendency in the infusion and post-infusion intervals. The decrease in the infusion interval was more pronounced. In the "uninfluenced" interval the T4 concentrations increased step by step. In one heifer the concentration of T4 slightly increased during infusion. A decrease was recorded in the post-infusion and "uninfluenced" interval. Rectal examination in the 172nd hour revealed the original corpus luteum in three animals and the production of the corpus luteum in the same ovary was found in this period in one heifer. In the 88th hour this animal showed clinical manifestations of oestrus. On the basis of the dynamics of the studied hormones and clinical studies, the thyroid hormones can be regarded as an important secondary factor involved in the permanent cyclic changes in reproduction process.     

Effect of time of progesterone supplementation on serum progesterone and the conception rate of cooled Holstein heifers during the summer

To investigate the effects of progesterone supplementation at two different times on serum progesterone (P₄) concentration, conception rate and resynchronization of cooled Holstein heifers in summer, 90 heifers were randomly assigned to two groups: (i) heifers subjected to TAI (timed artificial insemination) and progesterone supplementation from days 4 to 14 after TAI (S_1; n = 45); and (ii) heifers under the same TAI protocol as S₁ and progesterone supplementation from days 17 to 22 after TAI (S₂; n = 45). The groups S₁ and S₂ were cooled 10 days before and 21 days after TAI. Respiratory rate, body surface temperature, vaginal temperature and rectal temperature recorded during the experiment were not different (P > 0.05) between S₁ and S₂ groups. Progesterone concentration was not different (P > 0.05) in S₁ compared to S₂. The conception rates on days 30 and 55 were similar between groups (P > 0.05). Progesterone supplementation did not increase either conception rate or concentrations of P₄ in heifers during the summer. Heifers not pregnant to first service in the group S₂ were resynchronized (77.7%) for a second breeding.     

Insemination of Holstein heifers at a preset time after estrous cycle synchronization using progesterone and prostaglandin

Two experiments were conducted to study estrous cycle control regimens that combine progesterone administration via an intravaginal device ( PRID ) with a single injection of prostaglandin F2 alpha (PG). In Exp. I, 242 Holstein heifers were assigned randomly to one of three treatment groups at 14 to 18 mo of age. Treatments were: 1) control, 2) PRID -6 + PG-6 ( PRID in place for 6 d plus PG on the day of PRID removal) and 3) PRID -7 + PG-6 ( PRID in place for 7 d plus PG on the day before PRID removal). Heifers were observed for estrous activity and were inseminated at 8 to 20 h after estrus was detected. Estrus and ovulation were effectively synchronized after both PRID + PG treatments. Ninety-nine percent of the heifers in each group were in estrus within 168 h after PG injection. However, the interval from PG administration to the onset of estrus was longer after PRID -7 + PG-6 (75 +/- 2 h) than after PRID -6 + PG-6 (66 +/- 2 h). A lower variance in the interval from PG treatment to estrus was observed after PRID -7 + PG-6, suggesting that the 24 h delay in PRID withdrawal improved the synchrony of the onset of estrus. Pregnancy rates (72 to 82%) did not vary across treatment groups. Two-hundred seventy-four heifers were assigned to Exp. II. Treatments were 1) control, 2) 2 X PG (two injections of PG at an 11 d interval) and 3) PRID -7 + PG-6.(ABSTRACT TRUNCATED AT 250 WORDS)     

Leptin infusion during the early luteal phase in ewes does not affect progesterone production

Infusion of leptin during the ovine follicular phase has been shown to increase progesterone secretion during the subsequent luteal phase. In this study, we have assessed the effects of infusing leptin during the early luteal phase. Infusion of leptin (2.5 microg/h) into the ovarian artery of ewes with ovarian autotransplants (n=5) on day 3 of the luteal phase for 12h did not affect progesterone estradiol or LH concentrations compared to control ewes (n=5). These results suggest no direct effect of leptin on ovarian function at this stage of the estrous cycle.     

Relationships between the conception rate of estrus synchronization using estradiol benzoate and CIDR (progesterone) and other parameters in holstein lactating dairy cows

The purpose of this study was to determine the relationships between conception rate and other parameters before estrus synchronization with a Controlled Internal Drug Release Device (CIDR) and estradiol benzoate (EB). In the estrus synchronization program, animals were injected with 2 mg EB and then received a CIDR. Seven days later, the CIDR was removed and the animals were given an injection of Prostaglandin F(2alpha). Twenty-four hours later, they received an injection of 1 mg EB, and they were artificially inseminated 24 h after that. This program was applied to 258 Holstein cows in Tohoku-machi (Aomori, Japan). Blood was collected at the beginning of the program, and the conception rate was determined about 40 days after insemination. The relationships among conception rate, blood biochemical values, age, body condition score and days in milk were statistically analyzed to determine better conditions for cow conception. The conception rate of the cows in the high progesterone group (more than 1 ng/ml, P(4)+) was significantly higher than that of the low progesterone group (less than 1 ng/ml, P(4)-; 47.9% vs. 28.6% P<0.01). In the P(4)- groups, the serum phospholipid level was significantly higher in the conception group than in the non-conception group, and the same tendency was seen in the P(4)+ groups. Blood urea nitrogen (BUN), albumin (Alb), and total cholesterol (TChol) were significantly higher in the conception group compared with the non-conception group, but no with P(4) was observed. We concluded that 1) the conception rate of the P(4)- group was remarkably low, that 2) the low conception rate and low P(4) level was related to a low PL level and that 3) BUN, Alb and TChol were higher in the conception group, although no relation with P(4) was found.     

The therapeutic effects of a progesterone-releasing intravaginal device (PRID) with attached estradiol capsule on ovarian quiescence and cystic ovarian disease in postpartum dairy cows

The objective of this study was to evaluate the effects of a progesterone-releasing intravaginal device (PRID) containing an estradiol benzoate capsule on ovarian dysfunction, including ovarian quiescence, follicular cyst (FC) and luteal cyst or cystic corpus luteum (LC/CCL), in postpartum dairy cows. These ovarian dysfunctions were examined by palpation per rectum relative to plasma progesterone status. The results of clinical examination and hormone assay determined ovarian quiescence in 13 cows, FC in 15 cows and LC/CCL in 7 cows. These cows were treated with PRID for 12 d and then clinical examination was performed. After PRID removal, the proportion of cows exhibiting estrous signs within 7 d and confirmed formation of CL within 7-14 d (markedly effective) were 69.2 % (n=9) for ovarian quiescence, 46.7 % (n=7) for FC, and 28.6 % (2 cows) for LC/CCL. Two cows (15.4 %) in ovarian quiescence, 5 cows (33.3%) with FC and 4 cows (57.1 %) with LC/CCL did not exhibit estrous signs but were recognized as having formed CL within 12-16 d after removal of PRID (effective). These results suggest that treatments of PRID with estradiol benzoate for 12 d have therapeutic efficacy on ovarian dysfunction including ovarian quiescence, FC and LC/CCL in postpartum dairy cows.     

乏情母犬用溴隐亭处理后的发情表现与血清中孕酮和雌二醇水平变化

选择 3只年龄为 3岁处于乏情期的苏北红犬和 6只 1～ 2岁未发情的罗威纳犬 ,用溴隐亭处理后有 4只母犬发情 ,1只母犬受孕而后流产。分析犬血清中雌二醇和孕酮水平 ,发情受孕犬雌二醇和孕酮分泌呈现规律性变化趋势 ;发情未受孕犬在雌二醇分泌峰出现后孕酮分泌不稳定 ;而未发情犬雌二醇和孕酮没有变化。结果表明 ,溴隐亭能够有效地缩短母犬的乏情期 ,溴隐亭处理后不同生理状态母犬反应差异较大 ,发过情的母犬作用明显 ,对从未发过情的母犬效果较差     

Calving rate following fixed time insemination after a 12-day progesterone treatment in dairy cows, beef cows and heifers.

Farm trials were carried out to determine if cows and heifers could be inseminated on a fixed time basis following a 12-day treatment with progesterone coils and an injection of 5 mg oestradiol benzoate and 200 mg progesterone at the start of treatment. The retention rate of the coils was significantly higher (P less than 0.05) when a 5.5 cm diameter was used compared with a diameter of 7.0 cm. Calving rate was similar in treated cows bred at a detected oestrus, at 56 + 74 hours after treatment or at 56 hours after treatment and injection of 100 microgram gonadotrophin releasing hormone 20 hours previously and in control cows bred at oestrus. Fertility to the first repeat oestrus was also similar in treated and control cows. Significantly (P less than 0.05) more synchronised cows calved following fixed time AI compared with the calving rate in control cows inseminated for a 24-day experimental period. In beef suckler cows, calved at least 50 days, and dairy heifers weighing over 280 kg, calving rate was similar in treated animals bred at 56 and 74 hours after treatment compared to calving rate in control animals bred at oestrus.     

Effects of GnRH or progesterone treatment on day 5 post-AI on plasma progesterone, luteal blood flow and leucocyte counts during the luteal phase in dairy cows

This study was designed to test the effects of progesterone or GnRH treatment on day 5 post-AI on fertility and luteal function in dairy cows and heifers. Five days after AI, 32 animals were randomly assigned to a control, intravaginal progesterone for 14 days progesterone releasing intravaginal device (PRID) or GnRH treatment group. On days 5, 7, 12, 14, 17 and 19 post-AI, each animal underwent colour Doppler ultrasonography of the corpus luteum and blood samples were collected for cell counts and plasma progesterone determination. Through general linear model repeated measures analysis of variance, significant effects were observed of treatment, parity, inseminating bull, reduced vascularization of the CL and pregnancy on plasma progesterone concentrations, whereas mean plasma progesterone and time luteal phase day, and treatment and plasma progesterone concentration on day 5 post-AI were found to, respectively, affect neutrophil and lymphocyte counts throughout the luteal phase. Moreover, two binary logistic regression analyses were performed. Based on the odds ratio, the likelihood of pregnancy by days 26-32 post-AI was 23.4 times higher in animals with high mean progesterone levels throughout the study period, compared with animals with low mean progesterone. The likelihood of reduced CL vascularization was 14 times higher in animals treated with PRID, compared with control and GnRH-treated animals. In conclusion, our results indicate that treatment on day 5 post-AI with PRID reduced subsequent CL vascularization, whereas GnRH treatment increased plasma progesterone concentrations on day 12 post-AI, although an effect was identified of the inseminating bull on plasma progesterone levels. Pregnant animals showed higher mean plasma progesterone concentrations than in nonpregnant ones and heifers higher than in lactating cows, whereas blood cell counts differed depending on the treatment and on the mean plasma progesterone concentration on day 5 post-AI.     

Hormonal changes and follicular activity after treatment with intravaginal progesterone‐releasing devices in llamas

Plasma progesterone (P₄) concentrations and follicular activity after administration of different P₄ doses were evaluated in 33 adult female llamas treated with intravaginal devices. In Study 1, a group of llamas (n = 10) was treated with an intravaginal device (IVD) containing 160 (n = 5) or 780 mg of P₄ (n = 5). Based on the results from the first study, in Study 2, females with follicles at different stages of development were treated with the IVD containing 780 mg of P₄ (n = 21) or remain untreated (control; n = 12) to evaluate the effect of P₄ on follicular activity. In Study 1, the IVD containing 160 mg of P₄ induced follicular turnover in 60% of females while the remaining 40% of llamas developed persistent follicles. Thus, this device controlled follicular activity in llamas, although it promotes the persistence of follicles present at start of treatment. Conversely, in both studies, the IVD containing 780 mg of P₄ suppressed follicular development and hasten the emergence of a new follicular wave in all females regardless of the follicular phase at insertion. Additionally, in Study 2, this device effectively concentrated the appearance of follicles with ovulatory diameter at a definite time after treatment in comparison with control animals. In conclusion, treatment with an IVD containing 780 mg of P₄ would be considered for the control of follicular activity in llamas as it ensures the presence of a young follicle with ovulatory diameter by day 6 after the end of treatment in all females.     

Estrous synchronization using an intravaginal progesterone device in combination with gnrh or estradiol benzoate characterized by the initial ovarian conditions in Japanese black cows

Estrous synchronization using a Controlled Internal Drug Releasing device (CIDR) in combination with GnRH or estradiol benzoate (EB) treatment was investigated in Japanese black cows characterized with initial ovarian conditions. A total of 142 cows were allocated to one of four treatments: insertion of CIDR for eight days (Group A: n=34), CIDR with 100 microg of GnRH on d 0 (Group B: n=54, d 0=CIDR insertion), CIDR with GnRH on d 0 and 1 mg of EB on d 10 (Group C: n=20) or CIDR with 2 mg of EB on d 0 and 1 mg of EB on d 9 (Group D: n=34). All cows received 25 mg of PGF(2alpha) on d 7 and blood was collected for progesterone (P4) analysis on d 0, 8, and 21. AI was performed at estrus, but in Group D timed AI was set following a day of EB treatment. Estrus was induced in 141/142 cows, and the majority of which occurred on d 10 and 11 (98 cows, 34 cows). GnRH treatment induced more intermediate ovulation than EB treatment in cows with CL on d 0 (19.0% vs. 0%). Ovulation after CIDR removal was significantly higher in cows with CL on d 0 compared to those without CL (87.0% vs. 71.4%). Group B showed higher conception rates than those combined with Groups C and D where EB was injected after CIDR removal (51.1% vs. 38.9%). Conception had no correlation with either CL existence on d 0 or intermediate ovulation on d 8. P4 concentrations on d 8 were significantly lower compared to those on d 0 or d 21. On d 21 in cows without intermediate ovulation, Group A showed significantly lower P4 concentrations than the other 3 groups. The data suggests that CIDR insertion with PGF(2alpha) treatment is an effective method for estrous synchronization irrespective of initial ovarian conditions, and GnRH treatment at CIDR insertion induces intermediate ovulation and improves the conception rate in Japanese black cows.